Raltegravir EP impurity C

Raltegravir EP impurity C 구조식 이미지
카스 번호:
1391918-17-4
상품명:
Raltegravir EP impurity C
동의어(영문):
Raltegravir EP impurity C;Raltegravir USP Impurity E;Raltegravir Oxalylacetohydrazide Analog;Raltegravir Impurity 3(Raltegravir EP Impurity C);2-(2-(2-(2-Acetylhydrazinyl)-2-oxoacetamido)propan-2-yl)-N-(4-fluorobenzyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidine-4-carboxamide (Raltegravir Impurity);Acetic acid, 2-[[1-[4-[[[(4-fluorophenyl)methyl]amino]carbonyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-pyrimidinyl]-1-methylethyl]amino]-2-oxo-, 2-acetylhydrazide
CBNumber:
CB34634901
분자식:
C20H23FN6O6
포뮬러 무게:
462.43
MOL 파일:
1391918-17-4.mol

Raltegravir EP impurity C 속성

용해도
DMSO(약간 용해됨), 메탄올(약간 용해됨)
물리적 상태
고체
물리적 상태
단단한 모양
색상
흰색에서 황백색까지
안정성
감광성

안전

Raltegravir EP impurity C C화학적 특성, 용도, 생산

용도

2-Des(5-methyl-1,3,4-oxadiazole-2-carboxamide) 2-(2-(2-Acetylhydrazinyl)-2-oxoacetamide) Raltegravir is an impurity of a potent human immunodeficiency virus (HIV) integrase inhibitor. A novel anti-AIDS drug.

Raltegravir EP impurity C 준비 용품 및 원자재

원자재

준비 용품


Raltegravir EP impurity C 공급 업체

글로벌( 17)공급 업체
공급자 전화 이메일 국가 제품 수 이점
CR Corporation Lomited

fred.wen@crcorporation.cn CHINA 12069 58
Guangzhou PI PI Biotech Inc 020-81716320 +86-13602409664
Sales@pipitech.com China 3635 55
Shanghai CR Corporation Limited 4006653949
fred.wen@crcorporation.cn China 10054 58
TOSUN PHARM 020-61855200 13326451905
260366801@qq.com China 7582 58
Guangzhou Dreampharm Biotechnology Co., Ltd. 020-36607679 17825480238
3008233717@qq.com China 9896 12
Nanjing Shizhou Biology Technology Co.,Ltd 025-85560043 15850508050
info@synzest.com China 9287 58
Energy Chemical 021-58432009 400-005-6266
marketing1@energy-chemical.com China 44843 58
Nanjing Shizhou Biology Technology Co.,Ltd 18351873721
helen.zhang@synzest.com China 8298 58
Shenzhen Roark Pharma-Tec Co., Ltd. 13128912434
2880126944@qq.com China 2579 58
Shanghai YuZn Pharm. Technology Co.,Ltd. 15921286451; 15921286451
2010681527@qq.com China 5067 58

Copyright 2019 © ChemicalBook. All rights reserved